Examining the correlations between GSK-3 inhibitory properties and anti-convulsant efficacy of valproate and valproate-related compounds
- 15 November 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (22) , 5465-5467
- https://doi.org/10.1016/j.bmcl.2004.09.013
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- GSK-3: tricks of the trade for a multi-tasking kinaseJournal of Cell Science, 2003
- A common mechanism of action for three mood-stabilizing drugsNature, 2002
- Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and TeratogenJournal of Biological Chemistry, 2001
- Glycogen Synthase Kinase-3: Properties, Functions, and RegulationChemical Reviews, 2001
- The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3Journal of Neurochemistry, 2000
- Pharmacokinetics and Antiepileptic Activity of Valproyl Hydroxamic Acid DerivativesPharmaceutical Research, 1997
- Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study GroupPublished by American Medical Association (AMA) ,1994
- Anticonvulsant and Neurotoxic Activities of Twelve Analogues of Valproic AcidJournal of Pharmaceutical Sciences, 1993
- The effects of analogues of valproic acid on seizures induced by pentylenetetrazol and GABA content in brain of miceNeuropharmacology, 1983
- Valproic acid augments GABA-mediated postsynaptic inhibition in cultured mammalian neuronsBrain Research, 1979